| Phase 4 |
| NCT07589699 |
Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP |
Breast Cancer |
Not Yet Recruiting |
| NCT07600164 |
Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer |
HER2 + Breast Cancer |
Not Yet Recruiting |
| Phase 3 |
| NCT06430437 |
A Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic… |
Non-Small Cell Lung Cancer With HER2- Mutations |
Recruiting |
| NCT06828354 |
A Study of SHR-A1811 in Subjects With Ovarian Cancer |
Ovarian Cancer |
Recruiting |
| NCT07382687 |
Famitinib Combined With SHR-A1811, Versus SHR-A1811 for CDK4/6 Inhibitors-resistent… |
Breast Cancer |
Not Yet Recruiting |
| Phase 2 |
| NCT07309770 |
Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies |
Urachal Cancer |
Recruiting |
| NCT07340398 |
Neoadjuvant Trastuzumab-rezetecan Plus Pertuzumab or Nab-Paclitaxel, Carboplatin… |
HER2-positive Early Breast Cancer |
Recruiting |
| NCT07203729 |
The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low… |
HER2-Low Unresectable/Metastatic Breast Cancer Complicated With Visceral Crisis |
Recruiting |
| NCT05769010 |
Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases |
Metastatic Breast Cancer |
Recruiting |
| NCT06649331 |
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer |
Advanced Breast Cancer |
Recruiting |
| NCT07241793 |
Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in… |
Urothelial Carcinoma |
Recruiting |
| NCT07497386 |
A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast… |
Unresectable Locally Recurrent Breast Cancer |
Recruiting |
| NCT05582499 |
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study… |
Breast Neoplasm |
Recruiting |
| NCT07305246 |
Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for… |
Breast Cancer |
Not Yet Recruiting |
| NCT07317778 |
Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2… |
Breast Cancer Early Stage Breast Cancer (Stage 1-3) |
Not Yet Recruiting |
| NCT07416253 |
Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2… |
Breast Cancer |
Not Yet Recruiting |
| NCT07417241 |
SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast… |
Breast Cancer |
Not Yet Recruiting |
| NCT07466303 |
Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for… |
Breast Cancer |
Not Yet Recruiting |
| NCT07466927 |
Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With… |
HER2-negative Breast Cancer |
Not Yet Recruiting |
| NCT05924256 |
A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing |
Advanced Salivary Gland Carcinoma |
Active, Not Recruiting |
| NCT07528898 |
Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An… |
Breast Cancer |
Not Yet Recruiting |
| NCT07630077 |
Trastuzumab Rezetecan(SHR-A1811) Combined With Ivonescimab (AK112) in Locally Advanced or… |
Non Small Cell Lung Cancer |
Not Yet Recruiting |
| NCT07630103 |
Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast… |
Advanced Breast Cancer |
Not Yet Recruiting |
| NCT07631884 |
Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of… |
Solid Tumors |
Not Yet Recruiting |
| NCT07560475 |
Exploratory Study of SHR-A1811 Via Different Administration Routes in Patients |
HER2positive |
Not Yet Recruiting |